Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-12T14:43:59.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the detailed study content with an error page. As a result, the trial's title, conditions, locations, documents, and other structured data become inaccessible in this view.
    Difference
    18%
    Check dated 2026-09-21T21:57:15.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page shows an updated Revision tag from v3.6.5 to v3.6.6. This appears to be a minor platform update and does not change the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-31T16:51:36.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.6.5, replacing v3.6.4. This reflects an updated document state rather than changes to the study details or overall content.
    Difference
    0.0%
    Check dated 2026-08-10T12:53:39.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    A publication citation in the Publications section was updated to reflect a 2026 July version with a DOI, replacing the earlier print/online-ahead-of-print entry. This is a bibliographic update rather than a change to study data or conduct.
    Difference
    0.1%
    Check dated 2026-07-27T05:58:39.000Z thumbnail image

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.